enGene Holdings Statistics
Total Valuation
enGene Holdings has a market cap or net worth of $160.98 million. The enterprise value is -$31.05 million.
Important Dates
The last earnings date was Thursday, June 12, 2025, before market open.
Earnings Date | Jun 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
enGene Holdings has 51.11 million shares outstanding. The number of shares has increased by 199.07% in one year.
Current Share Class | 51.11M |
Shares Outstanding | 51.11M |
Shares Change (YoY) | +199.07% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 0.96% |
Owned by Institutions (%) | 38.11% |
Float | 24.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.71 |
P/TBV Ratio | 0.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.11.
Current Ratio | 12.66 |
Quick Ratio | 12.11 |
Debt / Equity | 0.11 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -29.39 |
Financial Efficiency
Return on equity (ROE) is -33.97% and return on invested capital (ROIC) is -21.13%.
Return on Equity (ROE) | -33.97% |
Return on Assets (ROA) | -20.35% |
Return on Invested Capital (ROIC) | -21.13% |
Return on Capital Employed (ROCE) | -35.37% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.40M |
Employee Count | 57 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, enGene Holdings has paid $248,000 in taxes.
Income Tax | 248,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.40% in the last 52 weeks. The beta is -0.39, so enGene Holdings's price volatility has been lower than the market average.
Beta (5Y) | -0.39 |
52-Week Price Change | -63.40% |
50-Day Moving Average | 3.72 |
200-Day Moving Average | 6.07 |
Relative Strength Index (RSI) | 37.76 |
Average Volume (20 Days) | 74,997 |
Short Selling Information
The latest short interest is 39,578, so 0.08% of the outstanding shares have been sold short.
Short Interest | 39,578 |
Short Previous Month | 34,169 |
Short % of Shares Out | 0.08% |
Short % of Float | 0.16% |
Short Ratio (days to cover) | 0.44 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -87.95M |
Pretax Income | -112.90M |
Net Income | -79.88M |
EBITDA | -87.81M |
EBIT | -87.95M |
Earnings Per Share (EPS) | -$1.68 |
Full Income Statement Balance Sheet
The company has $217.39 million in cash and $25.36 million in debt, giving a net cash position of $192.03 million or $3.76 per share.
Cash & Cash Equivalents | 217.39M |
Total Debt | 25.36M |
Net Cash | 192.03M |
Net Cash Per Share | $3.76 |
Equity (Book Value) | 227.29M |
Book Value Per Share | 4.45 |
Working Capital | 209.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$75.39 million and capital expenditures -$584,000, giving a free cash flow of -$75.98 million.
Operating Cash Flow | -75.39M |
Capital Expenditures | -584,000 |
Free Cash Flow | -75.98M |
FCF Per Share | -$1.49 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
enGene Holdings does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -199.07% |
Shareholder Yield | -199.07% |
Earnings Yield | -49.62% |
FCF Yield | -47.20% |
Analyst Forecast
The average price target for enGene Holdings is $23.29, which is 661.11% higher than the current price. The consensus rating is "Buy".
Price Target | $23.29 |
Price Target Difference | 661.11% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |